ANTICIPATING THE THERAPEUTIC AND CARE NEEDS OF TOMORROW
Pierre Fabre combines pharmaceutical and dermo-cosmetical research, thus creating original links between these two complementary activities. Over the years, this has resulted in wide-ranging expertise, such as plant research, the control of active substances of natural origin and dermatology.
Researchers convinced of the benefits of plants
Convinced that the 250,000 known flowering plants and some that are yet to be discovered are potential treasure chests of benefits to health and beauty, Pierre Fabre has made research on plant substances a major focus of its activities. To the group, plants constitute a source of multidisciplinary scientific investigation, aimed at identifying original, plant-based active substances that could be used equally to produce drugs and dermo-cosmetics products.
Sustained, targeted investments
The amounts invested in R&D by the Pierre Fabre's pharmaceutical division accounts for about 20% of its turnover - a percentage that is higher than the average in this sector, thus reflecting the strategic importance we assign to developing treatment solutions in our priority therapeutical franchises, primarily onco-hematology, dermatology and neuropsychiatry.
Benefiting from the pharmaceutical expertise of the group and permanent access to its drug laboratories, researchers in Pierre Fabre's dermo-cosmetical division have developed specific and unique capabilities in the cosmetics field. This has resulted in enriching the group's expertise and constitutes an active source of innovations.
Active substances and sustainable development
Pierre Fabre Laboratories have developed original expertise in three technology fields of the future. What these fields have in common is that they permit the development and production of new active substances, while addressing the growing need for sustainable development and "green" chemistry.